Hot Pursuit     18-May-24
Granules India Ltd gains for third consecutive session
Granules India Ltd is quoting at Rs 406.75, up 1.19% on the day as on 12:46 IST on the NSE. The stock is up 47.21% in last one year as compared to a 23.61% spurt in NIFTY and a 57.6% spurt in the Nifty Pharma index.

Granules India Ltd gained for a third straight session today. The stock is quoting at Rs 406.75, up 1.19% on the day as on 12:46 IST on the NSE. The benchmark NIFTY is up around 0.16% on the day, quoting at 22502. The Sensex is at 74005.94, up 0.12%. Granules India Ltd has slipped around 1.12% in last one month.

Meanwhile, Nifty Pharma index of which Granules India Ltd is a constituent, has slipped around 3.82% in last one month and is currently quoting at 18981.6, up 0.67% on the day. The volume in the stock stood at 1.69 lakh shares today, compared to the daily average of 9.04 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 407, up 0.33% on the day. Granules India Ltd is up 47.21% in last one year as compared to a 23.61% spurt in NIFTY and a 57.6% spurt in the Nifty Pharma index.

The PE of the stock is 22.33 based on TTM earnings ending March 24.

Previous News
  Granules India Ltd up for third consecutive session
 ( Hot Pursuit - 01-Oct-24   13:05 )
  Granules India unveils its Mobile Cancer Screening Unit at AIG Hospitals
 ( Corporate News - 24-Sep-24   14:40 )
  Granules India Ltd drops for fifth straight session
 ( Hot Pursuit - 17-Sep-24   13:35 )
  Granules India's Gagillapur FD facility completes USFDA inspection
 ( Corporate News - 12-Sep-24   15:19 )
  Granules India tumbles after Hyderabad facility gets six observations from USFDA
 ( Hot Pursuit - 12-Sep-24   15:15 )
  Granules India Ltd leads losers in 'A' group
 ( Hot Pursuit - 12-Sep-24   15:00 )
  Granules India’s Gagillapur facility completes USFDA inspection with 6 observations
 ( Hot Pursuit - 09-Sep-24   10:30 )
  Granules India Ltd soars 1.63%, up for third straight session
 ( Hot Pursuit - 21-Aug-24   13:05 )
  Granules Pharmaceuticals receives USFDA approval for Glycopyrrolate Oral Solution
 ( Corporate News - 20-Aug-24   15:24 )
  Granules India rises on USFDA nod for oral drug Glycopyrrolate
 ( Hot Pursuit - 20-Aug-24   14:00 )
  Granules India receives US FDA nod for depression treatment drug Trazodone
 ( Hot Pursuit - 09-Aug-24   14:52 )
Other Stories
  Tips Music Ltd up for third consecutive session
  03-Oct-24   13:05
  Colgate-Palmolive (India) Ltd soars 1.15%, up for fifth straight session
  03-Oct-24   13:00
  Malu Paper Mills Ltd leads gainers in 'B' group
  03-Oct-24   12:15
  ITD Cementation hit life high on Rs 1,937-cr order win
  03-Oct-24   12:14
  ITD Cementation India Ltd leads gainers in 'A' group
  03-Oct-24   12:00
  JSW Energy arm secures hydro storage project from MSEDCL
  03-Oct-24   11:57
  J.Kumar Infra rises on securing LoA for road project in Thane
  03-Oct-24   11:45
  Transformers and Rectifiers gains on bagging order worth Rs 565-cr
  03-Oct-24   11:16
  Volumes jump at Just Dial Ltd counter
  03-Oct-24   11:00
  PNB records 11% YoY growth in domestic deposits in Q2 FY25
  03-Oct-24   10:55
Back Top